Azithromycin 250 mg tablet
Pro Research Analysisby 
Searched over 200M research papers
Azithromycin 250 mg Tablet: Formulation and Manufacturing
Azithromycin 250 mg tablets are commonly produced using a direct compression method, which involves mixing non-dihydrate azithromycin with pharmaceutically acceptable excipients and compressing the mixture into tablets without the need for granulation. This approach simplifies manufacturing and ensures consistent tablet quality. The tablets can be formulated in various strengths, including 250 mg, 500 mg, and 600 mg, to accommodate different dosing needs .
Bioequivalence and Pharmacokinetics of Azithromycin 250 mg Tablets
Multiple studies have demonstrated that different formulations and brands of azithromycin 250 mg tablets are bioequivalent, meaning they provide similar rates and extents of absorption in the body. Studies conducted in both Chinese and international populations under fasting and fed conditions found that the maximum plasma concentration (Cmax) and area under the concentration–time curve (AUC) for generic and branded azithromycin tablets fall within the accepted bioequivalence range of 80%–125%. These findings confirm that patients can expect similar therapeutic effects from different azithromycin 250 mg tablet products, regardless of the manufacturer or whether the medication is taken with or without food 2356.
Clinical Uses and Efficacy of Azithromycin 250 mg Tablets
Azithromycin 250 mg tablets are widely used to treat bacterial infections and have shown effectiveness in several clinical scenarios. For example, in the treatment of posterior blepharitis, oral azithromycin 250 mg tablets (typically given as 500 mg on the first day, followed by 250 mg daily for four days) improved clinical signs and symptoms, although topical azithromycin was found to provide longer-lasting ocular benefits .
Azithromycin 250 mg tablets have also been used as prophylaxis for malaria, with daily dosing showing an efficacy of over 80% in preventing malaria in high-risk areas. This makes azithromycin a valuable alternative for individuals who cannot take other antimalarial drugs 78. Additionally, long-term daily use of azithromycin 250 mg has been shown to reduce exacerbation frequency and improve quality of life in patients with chronic obstructive pulmonary disease (COPD) .
Stability and Storage Considerations
The stability of azithromycin 250 mg tablets can vary depending on the formulation. Some brands may experience significant degradation when exposed to high temperatures (up to 60°C), while others remain stable. This highlights the importance of proper storage conditions to maintain the effectiveness of the medication, especially in hot climates .
Safety and Tolerability
Across various studies, azithromycin 250 mg tablets have been shown to be well tolerated, with most adverse events being mild and transient. This favorable safety profile supports their use in a wide range of patient populations and clinical settings 2357+1 MORE.
Conclusion
Azithromycin 250 mg tablets are a reliable and effective option for treating bacterial infections, preventing malaria, and managing chronic respiratory conditions. They are available in bioequivalent formulations from different manufacturers, can be taken with or without food, and are generally well tolerated. Proper storage is important to ensure drug stability, especially in warmer environments. Overall, azithromycin 250 mg tablets offer flexibility and efficacy for a variety of clinical needs.
Sources and full results
Most relevant research papers on this topic
The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension.
Food does not significantly decrease the bioavailability of azithromycin tablets, sachets, or suspension, allowing for once-daily, short-duration dosing regimens without meal consideration.
Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya.
Daily doxycycline and 250 mg azithromycin effectively prevent malaria in western Kenya, with daily azithromycin potentially being useful for individuals with contraindications to doxycycline treatment.
DOI
RESISTANT ANTI-MALARIAL DRUGS IN PLASMODIUM FALCIPARUM AND THE CURRENT STRATEGIES TO OVERCOME THEM
The nasal administration of azithromycin and chloroquine (AZCQ) shows potential for intermittent preventive treatment of malaria in pregnant women, with synergistic activity against chloroquine-resistant Plasmodium falciparum.
Estimating the Rate of Azithromycin Degradation Due to Increasing Temperature for Three Drug types by Spectrophotometer (UV) and Gas Chromatography-Mass Spectrometry (GC-MS)
Azithromycin concentration significantly decreases at 60°C, while other two drugs show no significant degradation, suggesting their stability in hot climate countries.
DOI